The Current Ratio as of December 2025 (TTM) for Arovella Therapeutics Limited (ALA.AX) is 14.18

According to Arovella Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 14.18. This represents a change of 65.69% compared to the average of 8.56 of the last 4 quarters.

Arovella Therapeutics Limited (ALA.AX) Historical Current Ratio (quarterly & annually)

How has ALA.AX Current Ratio performed in the past?

The mean historical Current Ratio of Arovella Therapeutics Limited over the last ten years is 4.31. The current 14.18 Current Ratio has changed 32.83% with respect to the historical average. Over the past ten years (40 quarters), ALA.AX's Current Ratio was at its highest in in the June 2025 quarter at 14.18. The Current Ratio was at its lowest in in the June 2018 quarter at 0.28.

Arovella Therapeutics Limited (ALA.AX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Arovella Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arovella Therapeutics Limited (ALA.AX) Average Current Ratio

How has ALA.AX Current Ratio performed in the past?

The current Current Ratio of Arovella Therapeutics Limited (ALA.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Arovella Therapeutics Limited (ALA.AX) Current Ratio vs. Peers

How is ALA.AX’s Current Ratio compared to its peers?

Arovella Therapeutics Limited’s Current Ratio is less than Island Pharmaceuticals Limited (22.27), greater than Alterity Therapeutics Limited (12.98), greater than Imugene Limited (1.88), greater than Actinogen Medical Limited (3.76), greater than Recce Pharmaceuticals Ltd (1.86), greater than EZZ Life Science Holdings Limited (5.77), greater than Biome Australia Limited (1.59), greater than Amplia Therapeutics Limited (7.91), greater than Alcidion Group Limited (1.14), greater than PainChek Limited (0.65),

Build a custom stock screener for Arovella Therapeutics Limited (ALA.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arovella Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arovella Therapeutics Limited (ALA.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arovella Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.